Signaturefd, LLC Forma Therapeutics Holdings, Inc. Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$7.12 - $20.24 $640 - $1,821	90 Added 28.85%	402 $8,000
Q2 2022 Aug 10, 2022	BUY	$5.1 - $10.0 $423 - $830	83 Added 36.24%	312 $2,000
Q1 2022 May 02, 2022	BUY	$8.34 - $14.69 $1,392 - $2,453	167 Added 269.35%	229 $2,000
Q4 2021 Jan 25, 2022	BUY	$13.6 - $24.89 $380 - $696	28 Added 82.35%	62 $1,000
Q3 2021 Oct 28, 2021	BUY	$21.22 - $25.7 $106 - $128	5 Added 17.24%	34 $1,000
Q2 2021 Jul 26, 2021	BUY	$22.86 - $30.95 $662 - $897	29 New	29 $1,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.